Breast cancer drug no longer approved by Food and Drug Administration
Avastin is a cancer drug developed by Genentech, a portion of Roche Pharmaceuticals. The FDA endorsement for Avastin was conditional. The Food and Drug Administration allowed it to be used only pending specific studies. Now that those studies have been carried out, the endorsement has been removed. Source of article: ...
